The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System-Reference-Cited by-同舟云学术

The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System

Published:2013-06-28 Issue:6 Volume:8 Page:e67904
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Geary Sean M.,Lemke Caitlin D.,Lubaroff David M.,Salem Aliasger K.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. (2012) Cancer Facts & Figures 2012. Atlanta: American Cancer Society.

2. Molecular mechanisms of drug resistance;DB Longley;J Pathol,2005

3. Monitoring cardiac function in patients receiving doxorubicin;P Lu;Semin Nucl Med,2005

4. Tipton JM (2003) Side effects of cancer chemotherapy. In: Skeel RT, editor. Handbook of Cancer Chemotherapy. Philadelphia: Lippincott Williams & Wilkins. 561–580.

5. Nanoparticle delivery systems in cancer vaccines;Y Krishnamachari;Pharm Res,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence;Cancer Letters;2024-07

2. Recent Advances in Drug Delivery;The AAPS Journal;2024-04-15

3. LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer;Developmental Cell;2023-09

4. Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products;Archivum Immunologiae et Therapiae Experimentalis;2023-07-06

5. Heterologous prime-boost vaccine using antigen-loaded microparticles and adenovirus (encoding antigen) enhances cellular immune responses and antitumor activity;International Journal of Pharmaceutics;2023-05